全球对乙型肝炎和型肝炎药物定价的比较
Leah Yao1, Xiaohan Ying1, Getan Malik2
1New York-Presbyterian / Weill Cornell Medical Center, 525 E 68th St, New York, NY 10021, USA.
Annals of hepatology
|May 25, 2025
概括
与其他国家相比,美国B型肝炎和C型肝炎抗病毒药物价格对于原始药物来说显著更高. 然而,在美国,仿制乙型肝炎药物更便宜,从而降低了患者的治疗费用.
科学领域:
- 药物经济学 药物经济学
- 全球卫生政策 全球卫生政策
- 肝病学 治疗学 治疗学
背景情况:
- 药品定价显著影响了美国的医疗保健支出,药品成本比同行国家高得多.
- 乙型肝炎 (HBV) 和型肝炎 (HCV) 的抗病毒疗法占这些成本的相当一部分.
相关概念视频
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Hepatic Drug Clearance: Role of Transporters
116
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
116
Hepatic Drug Excretion: Enterohepatic Cycling
1.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Hepatic Drug Excretion: Influencing Factors
244
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
244
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
228
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
228
Hepatic Drug Clearance: Effect of Protein Binding
301
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
301


